As DSRCTs harbor EWSR1-related translocations, they could be examined in clinical trials that target EWSR1 or its surrounding signaling molecules along with other Ewing-family tumors [30,33]. Here, EWSR1 is linked to Ewing sarcoma/peripheral primitive neuroectodermal tumor.